Longeveron Inc. (LGVN) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Longeveron Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.578 Greetings and welcome to the Lingeron 2025 Q3 Financial Results 00:00:05.578 -- 00:00:11.746 and Business Update Call. At this time, all participants are in a listen-only mode. 00:00:11.746 -- 00:00:14.590 Brief question and answer session will follow the formal presentation. 00:00:14.590 -- 00:00:19.616 If anyone should require operator assistance during the conference, please press 00:00:19.616 -- 00:00:22.980 star then zero on your telephone keypad. 00:00:22.980 -- 00:00:26.545 As a reminder, this conference is being recorded. 00:00:26.545 -- 00:00:28.634 It is now my pleasure to introduce your host. 00:00:28.634 -- 00:00:31.817 Derek Cole, Investor Relations. Thank you. 00:00:31.817 -- 00:00:34.058 You may begin. 00:00:34.520 -- 00:00:38.144 Thank you, Operator. Good afternoon, everyone, and thank you for joining us today to 00:00:38.144 -- 00:00:43.129 review Longevron's 2025 Third Quarter Financial Results and Business Update. 00:00:43.129 -- 00:00:46.933 After the U.S. markets closed today, we issued a press release with financial results 00:00:46.933 -- 00:00:48.996 for Q3 2025, 00:00:48.996 -- 00:00:53.140 which can be found under the Investors section of the Longevron website. 00:00:53.140 -- 00:00:57.913 On the call today with me are Thanh Pao, Interim Chief Executive Officer, Dr. 00:00:57.913 -- 00:01:02.741 Joshua Hare, co-founder, chief science officer, and executive chairman of the board. 00:01:02.741 -- 00:01:05.206 Dr. Natalia Agafanova, chief medical officer. 00:01:05.206 -- 00:01:10.656 Lisa Locklear, chief financial officer. And Devin Blass, chief technology officer. 00:01:10.656 -- 00:01:14.764 As a reminder, during this call, we will be making forward-looking statements. 00:01:14.764 -- 00:01:18.350 These stat...